PMDA drug package insert
静寂箋
PMDA OTC drug · ミライズ製薬株式会社 · package insert Nov 21, 2023
Key facts
| Brand names | 静寂箋 |
|---|---|
| Companies | 製造販売元／剤盛堂薬品（株）,販売会社／ミライズ製薬株式会社 |
| Product type | OTC drug |
| OTC risk class | 第２類医薬品 |
| OTC dosage form | 錠剤 |
| OTC effect category | 当帰芍薬散 |
| Package insert date | Nov 21, 2023 |
| PMDA document key | 300009_K2311000012 |
| PMDA company code | 300009 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: